Validation of the New HAG-B19 Scale for Measuring Lean & Fat Body Masse

Status Completed

Clinical Trial Summary

Body composition measurement is an important tool for assessing the physical condition of sick or healthy people, as well as for monitoring changes in body composition and physical performance during diet and/or training. Many people self-monitor their body composition using portable and inexpensive assessment tools, but most of them have not been tested for accuracy and precision. This study aims to assess the accuracy and precision of a new portable impedancemeter scale to measure body composition in comparison with proven techniques, such as 4-electrode electrical bioimpedance analysis and dual X-ray absorptiometry.

Clinical Trial Description

This is an observational, prospective, cross-sectional study to evaluate the accuracy and precision of the new HAG-B19 in healthy Western adults. A stratified sampling method is used to recruit a heterogeneous sample of 160 subjects, covering a wide range of ages and body compositions according to gender specific BMI distributions in the population. Volunteers who signed the informed consent form are included in the study. A financial compensation of 50.- CHF is given to each participant (100.- to the 16 participants subjected to the DEXA measurements). The body composition of each subject (FM, LBM and FM%) is assessed with sequential measurements using 3 HAG-B19 and 3 Nutriguard-M® devices (Data Input, Germany). FM% values measured by HAG-B19 are compared to values by Nutriguard-M® to assess the accuracy and precision of HAG-B19 (main objective). Intra- and inter-device variability are obtained by comparing the 3 repeated measurements and the 3 HAG-B19 devices (secondary objective). In a subgroup of 16 individuals, the FM% values measured by HAG-B19 are compared to DEXA measurements (secondary objective). Pearson correlations and Bland-Altman graphs are performed to assess the agreement of the measurements between the devices and paired t-tests are used to determine if there is a bias between the devices. The significance of the statistical analysis is fixed at p <0.05. ;

Study Design

Related Conditions & MeSH terms

Body Composition

Clinical Trial Details

NCT number	NCT04504799
Study type	Observational
Source	University Hospital, Geneva
Contact
Status	Completed
Phase
Start date	September 3, 2020
Completion date	February 25, 2021

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT05512559` - Body Composition Analysis and Time to Emergence From Remimazolam
Enrolling by invitation	`NCT05515835` - Relationship Between Effect Duration of Rocuronium and Body Composition Analysis Data.
Completed	`NCT04136821` - The Long-term Effects of Oceanix™ on Resistance Training Adaptations	N/A
Completed	`NCT03432130` - Injury Occurrence in Hip-hop Dance	N/A
Withdrawn	`NCT04021446` - A Supervised Clinic-to-Community Exercise Intervention to Improve Cardiometabolic Health in Survivors of AYA Cancer	N/A
Completed	`NCT02211612` - Overeating Different Fats and Influence on Muscle Mass and Body Fat Accumulation	N/A
Completed	`NCT03412578` - Effect of Tactile/Kinaesthetic Massage Therapy on DXA Parameter of Preterm Infants	N/A
Completed	`NCT02000492` - Frequent Ballgames Training for 9-11 Year Old Schoolchildren	N/A
Completed	`NCT01209936` - Hydration Factor Study for the Stayhealthy BC3	N/A
Recruiting	`NCT06061315` - Effect of Collagen Peptides, in Combination With Resistance Training, on Body Composition and Muscle Strength in Untrained Men	N/A
Completed	`NCT05730660` - Quercetin Phytosome® Chronic Fatigue Syndrome	N/A
Recruiting	`NCT04969588` - Kinect Equations for Body Indices and Body Composition
Completed	`NCT04828655` - Analysis of Bioparametric Measures for Correlating Daily Habits and Reducing Blood Pressure	N/A
Completed	`NCT04404413` - High-Intensity Interval Training and Intermittent Fasting on Body Composition and Physical Performance in Active Women	N/A
Completed	`NCT05052164` - Improvement Of Physical And Physiological Parameters In Menopausal Or Post-Menopausal Celiac Women	N/A
Completed	`NCT03352583` - Effects of Casein Timing on Body Composition and Performance	N/A
Enrolling by invitation	`NCT03587233` - Are Women With Higher Professional Status More Sedentary Compared to Men?	N/A
Recruiting	`NCT05556239` - STAY-STRONG Study of Exercise Training During Chemotherapy	N/A
Active, not recruiting	`NCT04306523` - Early Genetic and Environmental Influences on Eating - The Baylor Infant Twins Study
Suspended	`NCT00823329` - Calorie Balance Monitoring and Analysis of Body Composition and Hydration Status	Phase 0

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Validation of the New HAG-B19 Scale for Measuring Lean and Fat Body Masse — HAG-BIA

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms